Thompson Siegel & Walmsley’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Sell
16,862
-546
-3% -$148K 0.08% 238
2025
Q4
$4.37M Sell
17,408
-120
-0.7% -$31.9K 0.07% 233
2025
Q3
$5.03M Sell
17,528
-78
-0.4% -$20.9K 0.08% 221
2025
Q2
$4.62M Sell
17,606
-688
-4% -$168K 0.08% 217
2025
Q1
$4.26M Sell
18,294
-141,091
-89% -$34.2M 0.07% 207
2024
Q4
$36.5M Sell
159,385
-159,362
-50% -$36.6M 0.57% 66
2024
Q3
$71.2M Sell
318,747
-61,370
-16% -$13.5M 1.06% 27
2024
Q2
$77.4M Buy
380,117
+49,411
+15% +$10.1M 1.24% 18
2024
Q1
$72.2M Buy
330,706
+81,314
+33% +$17.9M 1.11% 24
2023
Q4
$56.7M Sell
249,392
-52,621
-17% -$11.1M 0.92% 34
2023
Q3
$60.7M Sell
302,013
-51,285
-15% -$10.8M 1.01% 35
2023
Q2
$73.2M Buy
353,298
+19,131
+6% +$3.71M 1.17% 24
2023
Q1
$65.9M Sell
334,167
-40,270
-11% -$8.29M 1.07% 27
2022
Q4
$75.7M Sell
374,437
-7,320
-2% -$1.43M 1.22% 21
2022
Q3
$67.2M Buy
381,757
+14,273
+4% +$2.92M 1.16% 24
2022
Q2
$74M Buy
367,484
+25,235
+7% +$5.38M 1.19% 25
2022
Q1
$77.5M Buy
342,249
+25,955
+8% +$6.1M 1.1% 28
2021
Q4
$85.4M Buy
316,294
+496
+0.2% +$123K 1.17% 23
2021
Q3
$76.4M Sell
315,798
-26,061
-8% -$6.57M 1.1% 28
2021
Q2
$81M Sell
341,859
-11,421
-3% -$2.6M 1.11% 27
2021
Q1
$77.4M Sell
353,280
-12,810
-3% -$2.57M 1.1% 35
2020
Q4
$64M Buy
366,090
+131,019
+56% +$22.6M 1.03% 37
2020
Q3
$38M Sell
235,071
-175,018
-43% -$27.7M 0.74% 51
2020
Q2
$58.5M Sell
410,089
-259,720
-39% -$35.9M 1.18% 29
2020
Q1
$72.7M Sell
669,809
-31,259
-4% -$4.5M 1.73% 5
2019
Q4
$102M Buy
701,068
+9,607
+1% +$1.39M 1.56% 9
2019
Q3
$99.8M Sell
691,461
-96,561
-12% -$14.1M 1.58% 9
2019
Q2
$117M Sell
788,022
-47,318
-6% -$6.6M 1.69% 4
2019
Q1
$110M Buy
835,340
+101,970
+14% +$12.6M 1.54% 8
2018
Q4
$79.6M Buy
733,370
+205,085
+39% +$27.5M 1.24% 20
2018
Q3
$78.8M Buy
528,285
+92,123
+21% +$14M 1.01% 36
2018
Q2
$67.3M Sell
436,162
-117,019
-21% -$17.7M 0.87% 44
2018
Q1
$76.9M Sell
553,181
-68,294
-11% -$10M 0.95% 41
2017
Q4
$85.2M Buy
621,475
+12,466
+2% +$1.65M 1.01% 36
2017
Q3
$79M Sell
609,009
-13,609
-2% -$1.82M 0.95% 35
2017
Q2
$82.4M Sell
622,618
-84,741
-12% -$10.4M 0.98% 33
2017
Q1
$87.2M Buy
707,359
+11,095
+2% +$1.31M 1.02% 26
2016
Q4
$76.8M Buy
696,264
+136,070
+24% +$15.1M 1.01% 22
2016
Q3
$66.2M Sell
560,194
-408,613
-42% -$48.1M 1.03% 15
2016
Q2
$108M Sell
968,807
-34,510
-3% -$3.71M 1.71% 2
2016
Q1
$101M Buy
1,003,317
+260,931
+35% +$25M 1.64% 2
2015
Q4
$78.9M Buy
742,386
+54,547
+8% +$5.63M 1.42% 4
2015
Q3
$64.1M Buy
687,839
+59,800
+10% +$6.19M 1.19% 7
2015
Q2
$65.4M Buy
628,039
+158,069
+34% +$16.5M 1.16% 8
2015
Q1
$50.9M Buy
469,970
+29,182
+7% +$3M 0.88% 20
2014
Q4
$40.9M Sell
440,788
-52,258
-11% -$4.62M 0.78% 27
2014
Q3
$43.1M Sell
493,046
-12
-0% -$1.08K 0.86% 17
2014
Q2
$43.4M Buy
493,058
+237,134
+93% +$20.5M 0.84% 15
2014
Q1
$21.6M Buy
255,924
+174,113
+213% +$13.9M 0.49% 66
2013
Q4
$6.42M Buy
81,811
+80,900
+8,880% +$6.9M 0.15% 229
2013
Q3
$78K Hold
911
﹤0.01% 436
2013
Q2
$78K Buy
+911
New +$75.6K ﹤0.01% 436

Other funds holding LH

Thompson Siegel & Walmsley's LH Position: Q1 2026 in Review

Thompson Siegel & Walmsley reduced its Labcorp (LH) stake by 3.1% in Q1 2026, selling an estimated $148K and leaving 16,862 shares worth $4.5M. The position accounts for 0.08% of the portfolio, ranked #238.

Thompson Siegel & Walmsley first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $117M in Q2 2019. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Thompson Siegel & Walmsley held 16,862 shares of Labcorp worth $4.5M as of Q1 2026.
  • Thompson Siegel & Walmsley sold 546 Labcorp shares in Q1 2026, an estimated $148K.
  • Labcorp made up 0.08% of Thompson Siegel & Walmsley's portfolio in Q1 2026, its #238 holding.
  • Thompson Siegel & Walmsley first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Thompson Siegel & Walmsley's Labcorp position peaked at $117M in Q2 2019.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2026, filed 11 May 2026.